Cargando…

Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation

RATIONALE & OBJECTIVE: Immunoglobulin A nephropathy (IgAN) is a common glomerular disease, with mesangial cell proliferation as a major feature. There is no disease-specific treatment. Platelet-derived growth factor (PDGF) contributes to the pathogenesis of IgAN. To better understand its pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Qi, Anderson, Joshua C., Zhang, Xian Wen, Huang, Zhi Qiang, Ebefors, Kerstin, Nyström, Jenny, Hall, Stacy, Novak, Lea, Julian, Bruce A., Willey, Christopher D., Novak, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664734/ https://www.ncbi.nlm.nih.gov/pubmed/34939009 http://dx.doi.org/10.1016/j.xkme.2021.06.007

Ejemplares similares

Mesangioproliferative Glomerulonephritis: A 30-Year Prognosis Study
por: Axelsen, Mette, et al.
Publicado: (2014)

The Glomerulus According to the Mesangium
por: Ebefors, Kerstin, et al.
Publicado: (2022)

Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis
por: Kuroda, Takayuki, et al.
Publicado: (2012)

Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center
por: Mokhtar, Ghadeer A., et al.
Publicado: (2014)

Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis
por: Guo, Ling, et al.
Publicado: (2017)

Takayasu arteritis: Association with mesangioproliferative glomerulonephritis in a 9-year-old child
por: Raghavan, R., et al.
Publicado: (2014)

Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions
por: Boi, Roberto, et al.
Publicado: (2022)

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?
por: Trimarchi, Hernán, et al.
Publicado: (2012)

Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2015)

IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment
por: Lai, Lingyun, et al.
Publicado: (2021)

Role of Glomerular Proteoglycans in IgA Nephropathy
por: Ebefors, Kerstin, et al.
Publicado: (2011)

Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats
por: Najar, Deman, et al.
Publicado: (2018)

Long-term clinical outcome for patients poisoned by the fungal nephrotoxin orellanine
por: Hedman, Heidi, et al.
Publicado: (2017)

Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report
por: Cheungpasitporn, Wisit, et al.
Publicado: (2011)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis
por: Du, Wen, et al.
Publicado: (2023)

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
por: Ebefors, Kerstin, et al.
Publicado: (2016)

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
por: Elíasdóttir, Sigridur, et al.
Publicado: (2023)

Mesangioproliferative glomerulonephritis with extracapillary crescents – unexpected fatal complication in a 17-year-old patient with implanted left ventricular assist device
por: Opriş, Elena Carmen, et al.
Publicado: (2020)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation
por: Zhou, Junsong, et al.
Publicado: (2018)

Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
por: Brown, Jessica E., et al.
Publicado: (2012)

Immune profile of IgA-dominant diffuse proliferative glomerulonephritis
por: Wallace, Eric, et al.
Publicado: (2014)

Proteoglycans contribute to the functional integrity of the glomerular endothelial cell surface layer and are regulated in diabetic kidney disease
por: Khramova, Alina, et al.
Publicado: (2021)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells
por: Cheng, Li-Chun, et al.
Publicado: (2018)

Intervention of AXL in EGFR Signaling via Phosphorylation and Stabilization of MIG6 in Non-Small Cell Lung Cancer
por: Yang, Ya-Yu, et al.
Publicado: (2023)

Immune Evasion Mechanism and AXL
por: Son, Hye-Youn, et al.
Publicado: (2021)

Patent Spring Washer Axles
Publicado: (1878)

Topology Optimization and Multiobjective Optimization for Drive Axle Housing of a Rear Axle Drive Truck
por: Zheng, Bin, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

The effect of androgen excess on maternal metabolism, placental function and fetal growth in obese dams
por: Fornes, Romina, et al.
Publicado: (2017)

Epigenetic regulation of AXL and risk of childhood asthma symptoms
por: Gao, Lu, et al.
Publicado: (2017)

AXL is an oncotarget in human colorectal cancer
por: Martinelli, Erika, et al.
Publicado: (2015)

Analysis of the Vehicle Chassis Axle Fractures
por: Decker, Živilė, et al.
Publicado: (2023)

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
por: Oien, Derek B., et al.
Publicado: (2018)

Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS‐mutated ovarian cancer cells with high AXL expression
por: Umemura, Shiori, et al.
Publicado: (2020)

AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
por: Landolt, Lea, et al.
Publicado: (2019)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uferepfli2v05tn4ejkit96gfn